N/A N=456 A Chatbot Intervention for Reducing HPV Vaccine Hesitancy
Cervical Cancer · Anal Cancer · Penile Cancer
Primary: Attitudes Toward HPV Vaccination — 3.86; 3.96; 3.41 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=17 A Study of Binimetinib and Encorafenib in Advanced BRAF Mutant Cancers
Advanced BRAF Mutant Cancers
Primary: Dose-limiting Toxicities (DLTs) — 0 DLTs
N/A N=40 Feasibility of Closed-loop Automated Insulin Delivery System by Primary Care & Endocrinology, in Person & Via Telehealth
Diabetes Mellitus, Type 1 · Type 1 Diabetes · Diabetes, Autoimmune
Primary: Percentage of Individuals With Mean CGM Glucose <183 mg/dL (Corresponding to an Estimated HbA1c of <8.0%) on Days 3-14, by Group. — 89; 100; 100; 100 percentage of…
N/A N=628 Twitter and Diabetes
Diabetes · Cardiovascular Disease
Primary: Change in Patient Activation Measure (PAM) Score From Baseline — 3.4; 0.0 score on a scale
Phase 2 N=17 Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA
Vulvar Atrophy
Primary: Number of Subjects With Treatment Emergent Adverse Events — 3; 2; 4; 3 Participants
N/A N=98 Evaluation Study of Talk Parenting Skills
Parenting Practices · Self Efficacy · Stress
Primary: Parenting and Family Adjustment Scales (PAFAS): Positive Encouragement Subscale — 2.53; 2.76 units on a scale — p=.690
N/A N=327 Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia
Schizophrenia · Schizoaffective Disorder · Schizophreniform Disorder
Primary: Number of Patients in Symptomatic Remission at Week 8 Comparing the "Switched" With the "Non Switched" Early Non-responders — 41; 25 Participants — p==0.01
Phase 2 N=71 Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.
Small Cell Lung Cancer · Soft Tissue Sarcoma · Triple-negative Breast Cancer
Primary: Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE V4.03 on Phase 1 — 3; 3; 3; 3 Participants
Phase 1 N=51 Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis and CVD Risk
Postmenopausal Osteoporosis · Gut Microbiota · Cardiovascular Diseases
Primary: Bone Mineral Density (BMD) — 1.14; 1.15; 1.17; 1.14 g/cm^2
N/A N=134 Comparative Effectiveness of Direct Admission & Admission Through Emergency Departments for Children
Hospitalization · Child Health
Primary: Timeliness of Clinical Care - Initial Therapeutic Management — 142; 153 minutes — p=<0.001
N/A N=666 ASPIRIN: Neurodevelopmental Follow-up Trial
Neurodevelopmental Abnormality
Primary: Bayley Scales of Infant and Toddler Development, 3rd Edition (Bayley-III) Cognitive Composite Score — 96; 96.8 score on a scale — p=0.25
Phase 4 N=60 Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chinese Adults
Urinary Tract Infection · Acute Pyelonephritis · Hospital Acquired Pneumonia
Primary: Percentage of Participants With Clinical Cure at Test of Cure (TOC) Visit - Microbiologically Modified Intent-to-Treat (mMITT) Analysis Set — 59.3; 25.9 Percentage of…
N/A N=1,459 Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis
Arthritis, Rheumatoid
Primary: Number of Participants With Treatment Escalations — 249; 130; 101; 48 Participants
N/A N=10 An Adaptive Intervention for Depression Among Latinos Living With HIV
Depression
Primary: Composite Measure of Feasibility for the Adaptive Treatment Strategy (ATS) — 5; 5; 4; 3 Participants
N/A N=42 FrAilty Care and wEll-funcTion in Community Dwelling Older Adults
Frailty · Sarcopenia · Aging
Primary: Pilot Evaluation - Percentage of Participants Retained at Follow up — 10; 10; 9; 11 Participants